Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator–Activated Receptor-γ Activation-Reference-Cited by-同舟云学术

Pulmonary Arterial Hypertension Is Linked to Insulin Resistance and Reversed by Peroxisome Proliferator–Activated Receptor-γ Activation

Published:2007-03-13 Issue:10 Volume:115 Page:1275-1284
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Hansmann Georg¹,Wagner Roger A.¹,Schellong Stefan¹,de Jesus Perez Vinicio A.¹,Urashima Takashi¹,Wang Lingli¹,Sheikh Ahmad Y.¹,Suen Renée S.¹,Stewart Duncan J.¹,Rabinovitch Marlene¹

Affiliation:

1. From the Department of Pediatrics, Division of Pediatric Cardiology (G.H., S.S., V.A.D.J.P., T.U., L.W., M.R.), Department of Medicine, Division of Cardiovascular Medicine (R.A.W.), and Department of Cardiovascular Surgery (A.Y.S.), Stanford University School of Medicine, Stanford, Calif, and Department of Medicine, Division of Cardiology, University of Toronto, Toronto, Ontario, Canada (R.S.S., D.J.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference51 articles.

1. Obesity and the Metabolic Syndrome in Children and Adolescents

2. The metabolic syndrome

3. The humoral side of insulin resistance

4. Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Expression Is Decreased in Pulmonary Hypertension and Affects Endothelial Cell Growth

5. Adipose-specific peroxisome proliferator-activated receptor knockout causes insulin resistance in fat and liver but not in muscle

Cited by 333 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Skeletal Muscle SIRT3 Deficiency Contributes to Pulmonary Vascular Remodeling in Pulmonary Hypertension Due to Heart Failure With Preserved Ejection Fraction;Circulation;2024-09-10

2. Pulmo-protection of long-term swimming exercise via improving insulin sensitivity in monocrotaline-induced pulmonary hypertensive rats;Biochemical and Biophysical Research Communications;2024-09

3. Empagliflozin Attenuates Pulmonary Arterial Remodeling Through Peroxisome Proliferator-Activated Receptor Gamma Activation;ACS Pharmacology & Translational Science;2024-08-01

4. Novel Tryptophan Hydroxylase Inhibitor TPT-001 Reverses PAH, Vascular Remodeling, and Proliferative-Proinflammatory Gene Expression;JACC: Basic to Translational Science;2024-07

5. Pathobiology of Pulmonary Arterial Hypertension;Current Respiratory Medicine Reviews;2024-05